Page 1,437«..1020..1,4361,4371,4381,439..1,4501,460..»

Stroke Assistive Devices Market to Remain Lucrative During 2018 2028 – Rapid News Network

Posted: Published on September 18th, 2019

After encountering stroke, a person usually goes to the physiotherapist for treatment or post-stroke recovery. The treatment may go wrong if the physiotherapist is not trained well, however, a patient receives quality treatment if these orthopedic treatment procedures are performed using robotic assistive devices. Stroke assistive devices are highly utilized in rehabilitation process to treat a physically disabled person in order to improve their daily performance Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Stroke Assistive Devices Market to Remain Lucrative During 2018 2028 – Rapid News Network

Neurotechnology holds the key to a healthy ageing population in 2050 – Financial Times

Posted: Published on September 18th, 2019

If we use history as a guide, it is unlikely that we will see a glorious transformation of all medicine over the next 30 years. Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Neurotechnology holds the key to a healthy ageing population in 2050 – Financial Times

New rehab facility for muscular function available to Manitobans – CTV News

Posted: Published on September 18th, 2019

Manitobans will no longer to travel outside the province for intensive muscular function rehab. The First Steps Wellness Centre, a rehabilitation facility that specializes in spinal injuries and neuro-muscular disorders, opened in Winnipeg this summer. Shane Hartje is centres the executive director and said in the past he had to travel to Regina, Sask. Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on New rehab facility for muscular function available to Manitobans – CTV News

#ECTRIMS2019 Glia Score May Differentiate Progressive MS, RRMS – Multiple Sclerosis News Today

Posted: Published on September 18th, 2019

Patients with progressive multiple sclerosis (MS) have higher levels of protein markers of activated glial cells than those with relapsing-remitting MS (RRMS) or patients with other neurological disorders, according to a new study. The findings also indicated that scoring the extent of glial involvement in relation to nerve cell damage in serum may help differentiate these two groups of MS patients. The research, Markers of glial processes and axonal damage in CSF and serum help to differentiate between relapsing-remitting and progressive forms of MS, was presented byAndr Huss, PhD, fromUniversity Hospital Ulm, Germany, at the35thCongress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), held in Stockholm Sept. Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on #ECTRIMS2019 Glia Score May Differentiate Progressive MS, RRMS – Multiple Sclerosis News Today

Tuesday, September 17, 2019 – Kaiser Health News

Posted: Published on September 18th, 2019

Connecticut To Eliminate Religious Exemptions For Vaccinations, Joining Handful Of Other States Connecticut is one of 31 states that reported measles cases this year, part of the worst outbreak of the disease in the U.S. since 1992. Meanwhile, in California, Gov Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Tuesday, September 17, 2019 – Kaiser Health News

LV Reverse Remodeling Not Improved by SGLT-2 Inhibitor – DocWire News

Posted: Published on September 18th, 2019

The inhibition of SGLT-2 was not associated with an improvement in left ventricular (LV) reverse remodeling in patients with type 2 diabetes mellitus (T2DM), new study results suggest. There is no known association between diastolic function parameters as determined by transthoracic echocardiography (TTE) and SGLT-2 inhibitor therapy, the paper authors, publishing in meeting supplement of the Journal of Cardiac Failure and presenting at the Heart Failure Society of American Scientific Meeting in Philadelphia. We hypothesized that in patients with T2DM the use of SGLT-2 inhibitors might improve TTE diastolic function parameters including LV mass and LV mass index Continue reading

Posted in Ventricular Remodeling | Comments Off on LV Reverse Remodeling Not Improved by SGLT-2 Inhibitor – DocWire News

Heart Failure Society of America 2019: Virtual Visits, Spironolactone Issues, and Reasons to Worry – DocWire News

Posted: Published on September 18th, 2019

The 2019 Heart Failure Society of America Scientific Meeting (HFSA 2019) in Philadelphia has wrapped up. DocWire News was there, and reports here on some interesting research from the meeting Continue reading

Posted in Ventricular Remodeling | Comments Off on Heart Failure Society of America 2019: Virtual Visits, Spironolactone Issues, and Reasons to Worry – DocWire News

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure – TCTMD

Posted: Published on September 18th, 2019

KIRKLAND, Wash Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure (HF), today announced the publication of the REDUCE FMR clinical study of its Carillon Mitral Contour System. Continue reading

Posted in Ventricular Remodeling | Comments Off on Reduce Fmr Study Shows Cardiac Dimensions’ Carillon System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure – TCTMD

Cardiac Restoration Systems Market Will Make a Huge Impact in Near Future – Wolf Mirror

Posted: Published on September 18th, 2019

As per a report published by National Heart, Lung, and Blood Institute (NHLBI), heart failure incidences continue to rise in the United States with approximately 825,000 new cases diagnosed in 2013. As per NHLBI, 5.1 million Americans over the age of 20 have heart failures and this number is projected to increase by 46% to reach 8 million by 2030. Cardiac restoration systems are usually used after a coronary artery bypass grafting and may precede or be followed by mitral valve repair or other procedures such as endocardectomy and cryoablation. Continue reading

Posted in Ventricular Remodeling | Comments Off on Cardiac Restoration Systems Market Will Make a Huge Impact in Near Future – Wolf Mirror

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF – TCTMD

Posted: Published on September 18th, 2019

PHILADELPHIA, PAPatients who have heart failure with reduced ejection fraction (HFrEF) achieve the most benefit in terms of survival and avoiding hospitalization when N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels are lowered quickly with sacubitril/valsartan, new data from the PROVE-HF trial show. The findings extend to patients with new-onset HF, and also suggest that even a suboptimal dose of the angiotensin receptor-neprilysin inhibitor (ARNI) gets the job done Continue reading

Posted in Ventricular Remodeling | Comments Off on New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF – TCTMD

Page 1,437«..1020..1,4361,4371,4381,439..1,4501,460..»